Features Pricing

Unlock Full Access Sign In

Your Feed

Workspace

Charts

Get access to all our reports for $50/mo

Read about the latest in the private markets and join a growing community.

Valuation Model
Expert Interviews
Founders, funding

Get Access

Benchling

#b2b

#biotechnology

Benchling revenue, growth, and valuation

Jan-Erik Asplund

Published Jun 28th, 2024

View PDF

Model

Click here to access our Benchling dataset.

The $210M/year GitHub of biotech

Free Report

Clio at $300M/year

Free Report

Hebbia

#ai

#b2b

Danny Wheller, VP of Business & Strategy at Hebbia, on vertical vs horizontal enterprise AI

Unlocked Report

Clay

#sales

#b2b

#productivity

Clay revenue, growth, and valuation

Unlocked Report

BillionToOne at $153M/yr

Free Report

BillionToOne

#biotechnology

BillionToOne revenue, growth, and valuation

Unlocked Report

View PDF

Featuring

Benchling

Benchling is a cloud-based informatics platform for bioscience R&D groups primarily serving life science academia and industry laboratories.

Listed In

#b2b

#biotechnology

Benchling revenue, growth, and valuation

Model

Read more from

Benchling

The $210M/year GitHub of biotech

Read more from
#b2b

Clio at $300M/year

Danny Wheller, VP of Business & Strategy at Hebbia, on vertical vs horizontal enterprise AI

Clay revenue, growth, and valuation

Read more from
#biotechnology

BillionToOne at $153M/yr

BillionToOne revenue, growth, and valuation

Create a free account, or log in.

Free article limit reached.

Standard membership required.

Standard membership required.

Model

Read more from Benchling

The $210M/year GitHub of biotech

Read more from #b2b

Clio at $300M/year

Danny Wheller, VP of Business & Strategy at Hebbia, on vertical vs horizontal enterprise AI

Clay revenue, growth, and valuation

Read more from #biotechnology

BillionToOne at $153M/yr

BillionToOne revenue, growth, and valuation

Read more from

Benchling

Read more from
#b2b

Read more from
#biotechnology